Cl[CH2:2][C:3]([N:5]1[CH2:10][CH2:9][CH:8]([CH2:11][CH2:12][O:13][C:14]2[CH:19]=[CH:18][C:17]([C:20]3[N:25]=[C:24]([C:26]#[N:27])[C:23]4[N:28]=[CH:29][N:30]([CH3:31])[C:22]=4[CH:21]=3)=[CH:16][C:15]=2[C:32]([F:35])([F:34])[F:33])[CH2:7][CH2:6]1)=[O:4].[CH:36]([N:39]([CH:42]([CH3:44])C)CC)([CH3:38])C.N1CCCC1>CO>[CH3:31][N:30]1[C:22]2[CH:21]=[C:20]([C:17]3[CH:18]=[CH:19][C:14]([O:13][CH2:12][CH2:11][CH:8]4[CH2:7][CH2:6][N:5]([C:3](=[O:4])[CH2:2][N:39]5[CH2:36][CH2:38][CH2:44][CH2:42]5)[CH2:10][CH2:9]4)=[C:15]([C:32]([F:34])([F:33])[F:35])[CH:16]=3)[N:25]=[C:24]([C:26]#[N:27])[C:23]=2[N:28]=[CH:29]1A mixture of 6-(4-(2-(1-(2-chloroacetyl)piperidin-4-yl)ethoxy)-3-(trifluoromethyl)phenyl)-1-methyl-1H-imidazo[4,5-c]pyridine-4-carbonitrile (25 mg), diisopropylethylamine (82 μL), and pyrrolidine (21 μL) in MeOH (1 ml) was stirred for 36 hours at room temperature. The mixture was purified by prep HPLC (acidic) to give the expected product (14 mg). 1H NMR (CD3OD) δ: 8.42 (s, 1H), 8.24-8.35 (m, 3H), 7.27 (d, 1H), 4.50 (d, 1H), 4.23 (t, 2H), 3.91-4.07 (m, 4H), 3.22-3.61 (m, 6H), 3.05 (t, 1H), 2.64 (t, 1H), 1.76-2.02 (m, 9H), 1.10-1.30 (m, 2H). MS m/z 541 (M+H).
Loading…